XENSURVI

Serial Number 88728919
606

Registration Progress

Application Filed
Dec 16, 2019
Under Examination
Nov 3, 2020
Approved for Publication
Sep 8, 2020
Published for Opposition
Sep 8, 2020
Registered

Trademark Image

XENSURVI

Basic Information

Serial Number
88728919
Filing Date
December 16, 2019
Published for Opposition
September 8, 2020
Abandonment Date
June 7, 2021
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jun 7, 2021
Classes
005

Rights Holder

TRAVERE THERAPEUTICS, INC.

03
Address
3611 VALLEY CENTRE DRIVE
SUITE 300
SAN DIEGO, CA 92130

Ownership History

Retrophin, Inc.

Original Applicant
03
San Diego, CA

Retrophin, Inc.

Owner at Publication
03
San Diego, CA

TRAVERE THERAPEUTICS, INC.

New Owner After Publication #1
03
SAN DIEGO, CA

Legal Representation

Attorney
Jared M. Barrett

USPTO Deadlines

All Deadlines Cleared

All 5 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

17 events
Date Code Type Description Documents
Jun 7, 2021 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Jun 7, 2021 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Dec 23, 2020 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Nov 3, 2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Sep 8, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 8, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Aug 19, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jul 31, 2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 28, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jul 28, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jul 28, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Feb 6, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
Feb 6, 2020 GNRT F NON-FINAL ACTION E-MAILED Loading...
Feb 6, 2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Feb 3, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 20, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 19, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of focal segmental glomerulosclerosis
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005